Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Estrov, Z.
Right arrow Articles by Aggarwal, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Estrov, Z.
Right arrow Articles by Aggarwal, B. B.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 94 No. 8 (October 15), 1999: pp. 2844-2853

Phenylarsine Oxide Blocks Interleukin-1beta -Induced Activation of the Nuclear Transcription Factor NF-kappa B, Inhibits Proliferation, and Induces Apoptosis of Acute Myelogenous Leukemia Cells

Zeev Estrov, Sunil K. Manna, David Harris, Quin Van, Elihu H. Estey, Hagop M. Kantarjian, Moshe Talpaz, and Bharat B. Aggarwal

From the Departments of Bioimmunotherapy, Molecular Oncology, and Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX.

Arsenic compounds have recently been shown to induce high rates of complete remission in patients with acute promyelocytic leukemia (APL). One of these compounds, As2O3, induces apoptosis in APL cells via a mechanism independent of the retinoic acid pathway. To test the hypothesis that arsenic compounds may be effective against other forms of acute myelogenous leukemia (AML), we studied the membrane-permeable arsenic compound phenylarsine oxide (PAO). Because interleukin-1beta (IL-1beta ) plays a key role in AML cell proliferation, we first tested the effect of PAO on OCIM2 and OCI/AML3 AML cell lines, both of which produce IL-1beta and proliferate in response to it. We found that PAO inhibited the proliferation of both OCIM2 and OCI/AML3 cells in a dose-dependent fashion (0.01 to 0.1 µmol/L) and that IL-1beta partially reversed this inhibitory effect. We then measured IL-1beta levels in these cells by using an enzyme-linked immunosorbent assay and Western immunoblotting and found that PAO almost completely abolished the production of IL-1beta in these AML cells, whereas it did not affect the production of IL-1 receptor antagonist. Because PAO inhibits activation of the transcription factor NF-kappa B and because NF-kappa B modulates an array of signals controlling cellular survival, proliferation, and cytokine production, we also studied the effect of PAO on NF-kappa B activation in AML cells and found that PAO suppressed the IL-1beta -induced activation of NF-kappa B. Because inhibition of NF-kappa B may result in cellular apoptosis, we also tested whether PAO may induce apoptotic cell death in AML cells. We found that PAO induced apoptosis in OCIM2 cells through activation of the cystein protease caspase 3 and subsequent cleavage of its substrate, the DNA repair enzyme poly (ADP-ribose) polymerase. The PAO-induced apoptosis was caspase dependent, because it was completely blocked by the caspase inhibitor Z-DEVD-FMK. Finally, we tested the effect of PAO on fresh AML marrow cells from 7 patients with newly diagnosed AML and found that PAO suppressed AML colony-forming cell proliferation in a dose-dependent fashion. Taken together, our data showing that PAO is an effective in vitro inhibitor of AML cells suggest that this compound may have a role in future therapies for AML.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Faderl, A. Pal, W. Bornmann, M. Albitar, D. Maxwell, Q. Van, Z. Peng, D. Harris, Z. Liu, I. Hazan-Halevy, et al.
Kit Inhibitor APcK110 Induces Apoptosis and Inhibits Proliferation of Acute Myeloid Leukemia Cells
Cancer Res., May 1, 2009; 69(9): 3910 - 3917.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. Marcucci, M. D. Radmacher, K. Maharry, K. Mrozek, A. S. Ruppert, P. Paschka, T. Vukosavljevic, S. P. Whitman, C. D. Baldus, C. Langer, et al.
MicroRNA Expression in Cytogenetically Normal Acute Myeloid Leukemia
N. Engl. J. Med., May 1, 2008; 358(18): 1919 - 1928.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. Sethi, B. Sung, and B. B. Aggarwal
Nuclear Factor-{kappa}B Activation: From Bench to Bedside
Experimental Biology and Medicine, January 1, 2008; 233(1): 21 - 31.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Ferrajoli, S. Faderl, Q. Van, P. Koch, D. Harris, Z. Liu, I. Hazan-Halevy, Y. Wang, H. M. Kantarjian, W. Priebe, et al.
WP1066 Disrupts Janus Kinase-2 and Induces Caspase-Dependent Apoptosis in Acute Myelogenous Leukemia Cells
Cancer Res., December 1, 2007; 67(23): 11291 - 11299.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Shishodia, G. Sethi, M. Konopleva, M. Andreeff, and B. B. Aggarwal
A Synthetic Triterpenoid, CDDO-Me, Inhibits I{kappa}B{alpha} Kinase and Enhances Apoptosis Induced by TNF and Chemotherapeutic Agents through Down-Regulation of Expression of Nuclear Factor {kappa}B-Regulated Gene Products in Human Leukemic Cells
Clin. Cancer Res., March 15, 2006; 12(6): 1828 - 1838.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. M. B. Kerbauy, V. Lesnikov, N. Abbasi, S. Seal, B. Scott, and H. J. Deeg
NF-{kappa}B and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs)
Blood, December 1, 2005; 106(12): 3917 - 3925.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. N. Bailey, D. M. Sabatini, and B. R. Stockwell
From The Cover: Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens
PNAS, November 16, 2004; 101(46): 16144 - 16149.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Shishodia and B. B. Aggarwal
Guggulsterone Inhibits NF-{kappa}B and I{kappa}B{alpha} Kinase Activation, Suppresses Expression of Anti-apoptotic Gene Products, and Enhances Apoptosis
J. Biol. Chem., November 5, 2004; 279(45): 47148 - 47158.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Veitonmaki, R. Cao, L.-H. Wu, T. L. Moser, B. Li, S. V. Pizzo, B. Zhivotovsky, and Y. Cao
Endothelial Cell Surface ATP Synthase-Triggered Caspase-Apoptotic Pathway Is Essential for K1-5-Induced Antiangiogenesis
Cancer Res., May 15, 2004; 64(10): 3679 - 3686.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Matta, Q. Sun, G. Moses, and P. M. Chaudhary
Molecular Genetic Analysis of Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein-induced NF-{kappa}B Activation
J. Biol. Chem., December 26, 2003; 278(52): 52406 - 52411.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Sun, S. Zachariah, and P. M. Chaudhary
The Human Herpes Virus 8-Encoded Viral FLICE-inhibitory Protein Induces Cellular Transformation via NF-{kappa}B Activation
J. Biol. Chem., December 26, 2003; 278(52): 52437 - 52445.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z. Estrov, S. Shishodia, S. Faderl, D. Harris, Q. Van, H. M. Kantarjian, M. Talpaz, and B. B. Aggarwal
Resveratrol blocks interleukin-1{beta}-induced activation of the nuclear transcription factor NF-{kappa}B, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells
Blood, August 1, 2003; 102(3): 987 - 995.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Q. Sun, H. Matta, and P. M. Chaudhary
The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation
Blood, March 1, 2003; 101(5): 1956 - 1961.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa Balpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis
Blood, February 1, 2003; 101(3): 1053 - 1062.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. D. Chen and C. L. Sawyers
NF-{kappa}B Activates Prostate-Specific Antigen Expression and Is Upregulated in Androgen-Independent Prostate Cancer
Mol. Cell. Biol., April 15, 2002; 22(8): 2862 - 2870.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Fiumara, V. Snell, Y. Li, A. Mukhopadhyay, M. Younes, A. M. Gillenwater, F. Cabanillas, B. B. Aggarwal, and A. Younes
Functional expression of receptor activator of nuclear factor kappa B in Hodgkin disease cell lines
Blood, November 1, 2001; 98(9): 2784 - 2790.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Stucki, A.-S. Rivier, M. Gikic, N. Monai, M. Schapira, and O. Spertini
Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination
Blood, April 1, 2001; 97(7): 2121 - 2129.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Chen, Y. Lu, Z. Zhang, V. Vallyathan, M. Ding, V. Castranova, and X. Shi
Opposite Effect of NF-kappa B and c-Jun N-terminal Kinase on p53-independent GADD45 Induction by Arsenite
J. Biol. Chem., March 30, 2001; 276(14): 11414 - 11419.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1999 by American Society of Hematology         Online ISSN: 1528-0020